Prognostic factors of non-Ampullary duodenal adenocarcinoma

Teijiro Hirashita, Masayuki Ohta, Kazuhiro Tada, Kunihiro Saga, Hiroomi Takayama, Yuichi Endo, Hiroki Uchida, Yukio Iwashita, Masafumi Inomata

Research output: Contribution to journalArticle

Abstract

Background: Non-Ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. Although several prognostic factors have been reported, they remain controversial due to the rarity of non-Ampullary duodenal adenocarcinoma. The aims of this study were to investigate prognostic factors in patients with non-Ampullary duodenal adenocarcinoma and to assess chemotherapy in patients with recurrence. Patients and methods: Records of 25 patients who underwent surgical treatment for nonampullary duodenal adenocarcinoma from 2004 to 2016 were retrospectively reviewed. The relationship between the clinicopathological factors and outcomes was investigated. Results: Serum level of CA19-9, gross appearance, tumor size, tumor invasion, lymph node metastases, TNM stage and lymphatic and vascular invasion were significant risk factors of recurrence. Patients with recurrence who received chemotherapy according to regimens used to treat colorectal cancer had a better prognosis than those without chemotherapy (P = 0.016). Conclusion: Advanced non-Ampullary duodenal adenocarcinoma has a poor prognosis, but chemotherapy possibly improves the prognosis in the patients with recurrent non-Ampullary duodenal adenocarcinoma.

Original languageEnglish
Pages (from-to)743-747
Number of pages5
JournalJapanese journal of clinical oncology
Volume48
Issue number8
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Adenocarcinoma
Drug Therapy
Recurrence
Ampulla of Vater
Rare Diseases
Blood Vessels
Colorectal Neoplasms
Neoplasms
Lymph Nodes
Neoplasm Metastasis
Carcinoma
Serum
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Hirashita, T., Ohta, M., Tada, K., Saga, K., Takayama, H., Endo, Y., ... Inomata, M. (2018). Prognostic factors of non-Ampullary duodenal adenocarcinoma. Japanese journal of clinical oncology, 48(8), 743-747. https://doi.org/10.1093/jjco/hyy086

Prognostic factors of non-Ampullary duodenal adenocarcinoma. / Hirashita, Teijiro; Ohta, Masayuki; Tada, Kazuhiro; Saga, Kunihiro; Takayama, Hiroomi; Endo, Yuichi; Uchida, Hiroki; Iwashita, Yukio; Inomata, Masafumi.

In: Japanese journal of clinical oncology, Vol. 48, No. 8, 01.01.2018, p. 743-747.

Research output: Contribution to journalArticle

Hirashita, T, Ohta, M, Tada, K, Saga, K, Takayama, H, Endo, Y, Uchida, H, Iwashita, Y & Inomata, M 2018, 'Prognostic factors of non-Ampullary duodenal adenocarcinoma', Japanese journal of clinical oncology, vol. 48, no. 8, pp. 743-747. https://doi.org/10.1093/jjco/hyy086
Hirashita T, Ohta M, Tada K, Saga K, Takayama H, Endo Y et al. Prognostic factors of non-Ampullary duodenal adenocarcinoma. Japanese journal of clinical oncology. 2018 Jan 1;48(8):743-747. https://doi.org/10.1093/jjco/hyy086
Hirashita, Teijiro ; Ohta, Masayuki ; Tada, Kazuhiro ; Saga, Kunihiro ; Takayama, Hiroomi ; Endo, Yuichi ; Uchida, Hiroki ; Iwashita, Yukio ; Inomata, Masafumi. / Prognostic factors of non-Ampullary duodenal adenocarcinoma. In: Japanese journal of clinical oncology. 2018 ; Vol. 48, No. 8. pp. 743-747.
@article{76a556bcff31431386203cf5e1c13bae,
title = "Prognostic factors of non-Ampullary duodenal adenocarcinoma",
abstract = "Background: Non-Ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. Although several prognostic factors have been reported, they remain controversial due to the rarity of non-Ampullary duodenal adenocarcinoma. The aims of this study were to investigate prognostic factors in patients with non-Ampullary duodenal adenocarcinoma and to assess chemotherapy in patients with recurrence. Patients and methods: Records of 25 patients who underwent surgical treatment for nonampullary duodenal adenocarcinoma from 2004 to 2016 were retrospectively reviewed. The relationship between the clinicopathological factors and outcomes was investigated. Results: Serum level of CA19-9, gross appearance, tumor size, tumor invasion, lymph node metastases, TNM stage and lymphatic and vascular invasion were significant risk factors of recurrence. Patients with recurrence who received chemotherapy according to regimens used to treat colorectal cancer had a better prognosis than those without chemotherapy (P = 0.016). Conclusion: Advanced non-Ampullary duodenal adenocarcinoma has a poor prognosis, but chemotherapy possibly improves the prognosis in the patients with recurrent non-Ampullary duodenal adenocarcinoma.",
author = "Teijiro Hirashita and Masayuki Ohta and Kazuhiro Tada and Kunihiro Saga and Hiroomi Takayama and Yuichi Endo and Hiroki Uchida and Yukio Iwashita and Masafumi Inomata",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/jjco/hyy086",
language = "English",
volume = "48",
pages = "743--747",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Prognostic factors of non-Ampullary duodenal adenocarcinoma

AU - Hirashita, Teijiro

AU - Ohta, Masayuki

AU - Tada, Kazuhiro

AU - Saga, Kunihiro

AU - Takayama, Hiroomi

AU - Endo, Yuichi

AU - Uchida, Hiroki

AU - Iwashita, Yukio

AU - Inomata, Masafumi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Non-Ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. Although several prognostic factors have been reported, they remain controversial due to the rarity of non-Ampullary duodenal adenocarcinoma. The aims of this study were to investigate prognostic factors in patients with non-Ampullary duodenal adenocarcinoma and to assess chemotherapy in patients with recurrence. Patients and methods: Records of 25 patients who underwent surgical treatment for nonampullary duodenal adenocarcinoma from 2004 to 2016 were retrospectively reviewed. The relationship between the clinicopathological factors and outcomes was investigated. Results: Serum level of CA19-9, gross appearance, tumor size, tumor invasion, lymph node metastases, TNM stage and lymphatic and vascular invasion were significant risk factors of recurrence. Patients with recurrence who received chemotherapy according to regimens used to treat colorectal cancer had a better prognosis than those without chemotherapy (P = 0.016). Conclusion: Advanced non-Ampullary duodenal adenocarcinoma has a poor prognosis, but chemotherapy possibly improves the prognosis in the patients with recurrent non-Ampullary duodenal adenocarcinoma.

AB - Background: Non-Ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. Although several prognostic factors have been reported, they remain controversial due to the rarity of non-Ampullary duodenal adenocarcinoma. The aims of this study were to investigate prognostic factors in patients with non-Ampullary duodenal adenocarcinoma and to assess chemotherapy in patients with recurrence. Patients and methods: Records of 25 patients who underwent surgical treatment for nonampullary duodenal adenocarcinoma from 2004 to 2016 were retrospectively reviewed. The relationship between the clinicopathological factors and outcomes was investigated. Results: Serum level of CA19-9, gross appearance, tumor size, tumor invasion, lymph node metastases, TNM stage and lymphatic and vascular invasion were significant risk factors of recurrence. Patients with recurrence who received chemotherapy according to regimens used to treat colorectal cancer had a better prognosis than those without chemotherapy (P = 0.016). Conclusion: Advanced non-Ampullary duodenal adenocarcinoma has a poor prognosis, but chemotherapy possibly improves the prognosis in the patients with recurrent non-Ampullary duodenal adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85052634196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052634196&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyy086

DO - 10.1093/jjco/hyy086

M3 - Article

C2 - 29931295

AN - SCOPUS:85052634196

VL - 48

SP - 743

EP - 747

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 8

ER -